Rajasthan cough syrup deaths

  • Health Ministry Confirms No Toxins in Cough Syrup Linked to Children

    Health Ministry Confirms No Toxins in Cough Syrup Linked to Children's Deaths, Issues New Safety Guidelines

    Oct 03, 2025 09:24 pm CST

    The Union Health Ministry reports that cough syrup samples connected to children's deaths in Rajasthan and Madhya Pradesh contained no kidney-damaging toxins, but has issued new restrictive guidelines for pediatric cough medicine use. Despite negative test results for diethylene glycol and ethylene glycol, the government advises against giving these medications to children under two years of age following multiple fatalities that prompted regional bans on specific products.

  • Deadly Cough Syrup Investigation: Multiple Child Deaths in Rajasthan Linked to Kayson Pharma Product

    Deadly Cough Syrup Investigation: Multiple Child Deaths in Rajasthan Linked to Kayson Pharma Product

    Oct 03, 2025 07:24 pm CST

    Rajasthan authorities have launched an investigation into Kayson Pharma following multiple child deaths linked to their cough syrup containing dextromethorphan hydrobromide. The medication, distributed through the state's free medicine scheme, has been suspended while officials examine the company's entire product line. Previous quality control issues raise questions about the pharmaceutical company's repeated government contracts despite past blacklisting.

  • Rajasthan Health Department Confirms Cough Syrup Deaths Not Linked to Government Medicine Scheme

    Rajasthan Health Department Confirms Cough Syrup Deaths Not Linked to Government Medicine Scheme

    Oct 03, 2025 12:15 pm CST

    The Rajasthan Health Department has officially ruled out any connection between child deaths in Bharatpur and Sikar districts and cough syrup distributed under the state's free medicine scheme. Investigations revealed the children received Dextromethorphan (DXM) at home without medical consultation, prompting authorities to suspend involved healthcare providers in a separate case and issue strict prescription guidelines to prevent future incidents.